The Bob Pinedo Cancer Care Award 2026 is a prestigious biennial international award recognizing outstanding contributions in translational cancer research and compassionate oncology care. The award provides €100,000 in research funding and is open to researchers or research teams worldwide. The nomination deadline is 15 May 2026, and submissions must be made in English via email using the official nomination form.
Overview
The Bob Pinedo Cancer Care Award honors exceptional achievements in:
-
Oncology
-
Translational cancer research
-
Compassionate cancer patient care
It recognizes a researcher or research team whose work has significantly advanced cancer science and improved patient-centered care.
The award highlights both past impact and future research potential, ensuring continued innovation in cancer treatment and care delivery.
Key Award Details
-
Award cycle: Every two years (biennial award)
-
Prize amount: €100,000
-
Use of funds: Finance or co-finance a research project within the laureate’s specialization
-
Additional recognition: Bronze sculpture symbolizing strength and hope of recovery
-
Submission deadline: 15 May 2026
-
Language requirement: English
What Is Translational Cancer Research?
Translational cancer research refers to the process of converting laboratory discoveries into clinical applications that benefit cancer patients.
It bridges:
-
Basic research (molecular biology, genetics, immunology)
-
Clinical research (trials, diagnostics, therapies)
-
Patient care implementation
Examples include:
-
Developing targeted therapies based on genetic findings
-
Translating biomarker discoveries into diagnostic tools
-
Implementing precision medicine strategies
-
Improving supportive and palliative oncology care
The award emphasizes research that improves both scientific knowledge and real-world patient outcomes.
Who Is Eligible?
Eligible Nominees
Researchers or research teams who:
-
Are employed at a university or research institute
-
Work anywhere in the world
-
Have made pioneering contributions to translational cancer research
-
Have demonstrated excellence in compassionate cancer patient care
-
Show strong promise for continued scientific leadership
Who Can Submit Nominations?
-
Individual researchers
-
Research organizations worldwide
Ineligible Individuals
The following individuals cannot nominate or be nominated:
-
Members of the Academy board
-
Members of the foundation board
-
Members of the award jury
Why This Award Matters
The Bob Pinedo Cancer Care Award plays a vital role in the global oncology research ecosystem.
It:
-
Encourages innovation in cancer diagnostics and treatments
-
Promotes patient-centered and compassionate oncology care
-
Provides substantial research funding (€100,000)
-
Recognizes international scientific excellence
-
Supports sustainable, long-term impact in cancer research
By rewarding both scientific rigor and compassionate practice, the award strengthens the link between research and patient well-being.
Award Benefits
Financial Benefit
-
€100,000 dedicated to a research project
-
Can finance or co-finance ongoing or new research initiatives
Professional Recognition
-
International visibility
-
Validation of scientific impact
-
Award ceremony during a dedicated meeting and symposium
-
Symbolic bronze sculpture recognizing strength and hope
How to Apply: Step-by-Step Nomination Process
Follow these steps to submit a valid nomination:
-
Obtain the official nomination form from the awarding body.
-
Complete the form in English.
-
Prepare all required supporting documents and attachments.
-
Submit the full nomination package via email.
-
Wait for official confirmation of receipt from the Academy.
Important: A nomination is only considered valid after confirmation of receipt.
Deadline
All materials must be submitted before 15 May 2026. Late submissions will not be considered for the 2026 award cycle.
How the Selection Process Works
An expert jury appointed by the Academy board evaluates all eligible nominations.
Evaluation Criteria
Candidates are assessed based on:
-
Quality and impact of scientific research
-
Contributions to pioneering oncology research
-
Strength and influence of publications
-
International scientific recognition
-
Future promise and sustainability of research
Final Decision Process
-
Jury reviews nominations.
-
Jury submits an official recommendation.
-
The foundation allocates the award.
-
The award is presented at a dedicated meeting and symposium.
Common Mistakes to Avoid
-
Submitting after 15 May 2026
-
Failing to include required attachments
-
Submitting documents in a language other than English
-
Assuming submission is complete without receiving confirmation
-
Nominating individuals affiliated with the Academy board, foundation board, or jury
Carefully review eligibility and submission requirements before sending the nomination.
Frequently Asked Questions (FAQs)
1. What is the funding amount for the Bob Pinedo Cancer Care Award?
The award provides €100,000 to finance or co-finance a research project within the laureate’s specialization.
2. How often is the award presented?
The award is presented every two years.
3. Who can be nominated?
Researchers or research teams employed at universities or research institutes worldwide with outstanding contributions to translational cancer research and cancer patient care.
4. What language must nominations be submitted in?
All nominations must be submitted in English.
5. How is the winner selected?
An expert jury evaluates nominations based on scientific impact, innovation, international recognition, and future research potential.
6. When is the deadline for the 2026 award cycle?
The nomination deadline is 15 May 2026.
7. When is a nomination considered valid?
A nomination is valid only after official confirmation of receipt by the Academy.
Conclusion
The Bob Pinedo Cancer Care Award 2026 is a prestigious international recognition for excellence in translational oncology and compassionate cancer care. With €100,000 in funding and global recognition, it supports researchers who translate scientific discovery into meaningful patient impact.
Eligible nominators should ensure complete, English-language submissions are emailed before 15 May 2026 and confirmed by the Academy to secure consideration for this highly competitive biennial award.
For more information, visit KNAW.
